Teva Pharmaceutical Industries ($TEVA) is scheduled to release earnings before Monday's open (Feb 13, 2017). Teva hit a record high of $72.31/share in 2015 and is currently trading near $32/share.
The stock is prone to big moves after reporting earnings and can easily gap up if the numbers are strong. Conversely, if the numbers disappoint, the stock can easily gap down. To help you prepare, here is what the Street is expecting:
The stock is prone to big moves after reporting earnings and can easily gap up if the numbers are strong. Conversely, if the numbers disappoint, the stock can easily gap down. To help you prepare, here is what the Street is expecting:
Earnings Preview:
Teva is expected to report earnings of $1.32/share on $6.26 billion in revenue. Meanwhile, the so-called Whisper number is $1.34. The Whisper number is the Street's unofficial view on earnings.
Company Profile & Various Businesses:
Here is a complete company profile and description of the various businesses courtesy of my friends at Thomson Reuters Eikon:
Teva Pharmaceutical Industries Limited, incorporated on February 13, 1944, is a global pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company has a global portfolio of approximately 1,000 molecules.